Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-dose IPV booster by jet injector versus standard intramuscular IPV booster
NL-OMON26044Active, not recruiting
- Sponsor
- Intravacc
- Start
- Mar 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of trivalent inactivated polio vaccine in poliomyelitis (4 arms), sponsored by Intravacc. Primary endpoints: Safety of jet injector and intradermal IPV administration and Serum neutralizing antibody titers. Started Mar 2010; status: active, not recruiting.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NL-OMON26044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26044.